JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

Condition:   Relapsed or Refractory B-cell Lymphoma Intervention:   Biological: infusion of JY231 injection Sponsor:   Guangdong Second Provincial General Hospital Recruiting

Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials